Crossmark

Preparation of Erlotinib hydrochloride nanoparticles (anti-cancer drug) by RESS-C method and investigating the effective parameters

Published Online: 2024-06-28

Authors

Bazaei, Majid

Honarvar, Bizhan

Esfandiari, Nadia

Sajadian, Seyed Ali

Arab Aboosadi, Zahra
License Information

Text and Data Mining valid from 2024-06-28

Version of Record valid from 2024-06-28
More Information

Article History

Received: 22 December 2023

Accepted: 10 June 2024

First Online: 28 June 2024

Competing interests

: The authors declare no competing interests.

Document is current